Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Feb 20 EFFECT Notice of effectiveness
- 13 Feb 20 424B3 Prospectus supplement
- 6 Feb 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Jan 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Dec 19 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Oct 19 S-4 Registration of securities issued in business combination transactions
VTRS similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Pfizer Inc.:
We consent to the use of our report dated October 25, 2019, with respect to the combined balance sheets of Upjohn (a business unit of Pfizer Inc.) as of December 31, 2018 and 2017, the related combined statements of income, comprehensive income, equity, and cash flows for each of the years in the three-year period ended December 31, 2018, and the related notes, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
New York, New York
December 13, 2019